Viewing Study NCT00227656

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:38 PM
Ignite Modification Date: 2026-06-09 @ 10:38 PM
Study NCT ID: NCT00227656
Status: TERMINATED
Last Update Posted: 2012-12-11
First Post: 2005-09-26
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Capecitabine and Pegylated Interferon Alfa-2a in Treating Patients With Recurrent or Progressive Brain Metastases Due to Breast Cancer
Sponsor: M.D. Anderson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
None Metastatic Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None stage IV breast cancer View
None recurrent breast cancer View
None male breast cancer View
None tumors metastatic to brain View